GALT icon

Galectin Therapeutics

76 hedge funds and large institutions have $35.4M invested in Galectin Therapeutics in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$894K
Puts
$1.46M
Net Calls
Net Calls Change

Top Buyers

1 +$6.02M
2 +$1.73M
3 +$785K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$519K
5
AG
Advisor Group
Arizona
+$476K

Top Sellers

1 -$1.47M
2 -$891K
3 -$877K
4
CS
Credit Suisse
Switzerland
-$759K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$722K
Name Holding Trade Value Shares
Change
Change in
Stake
76
77
78
79
80
81
82
83
84
85
86
87
88